Operating Income (Loss) in USD of NP Life Sciences Health Industry Group Inc. from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
NP Life Sciences Health Industry Group Inc. quarterly/annual Operating Income (Loss) history and change rate from Q4 2018 to Q4 2023.
  • NP Life Sciences Health Industry Group Inc. Operating Income (Loss) for the quarter ending 31 Dec 2023 was -$35.9K, a 316% decline year-over-year.
  • NP Life Sciences Health Industry Group Inc. Operating Income (Loss) for the twelve months ending 31 Dec 2023 was -$690.000, a 96.3% increase year-over-year.
  • NP Life Sciences Health Industry Group Inc. annual Operating Income (Loss) for 2023 was -$690.000, a 96.3% increase from 2022.
  • NP Life Sciences Health Industry Group Inc. annual Operating Income (Loss) for 2022 was -$18.9K, a 71.3% increase from 2021.
  • NP Life Sciences Health Industry Group Inc. annual Operating Income (Loss) for 2021 was -$65.7K, a 49.9% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

NP Life Sciences Health Industry Group Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$690 -$35.9K -$52.5K -316% 01 Oct 2023 31 Dec 2023 10-K 16 Apr 2024
Q3 2023 $51.8K -$37.4K -$32K -588% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $83.8K $71.4K +$70.3K +6529% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $13.5K $1.23K +$32.3K 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023
Q4 2022 -$18.9K $16.6K -$15.5K -48.4% 01 Oct 2022 31 Dec 2022 10-K 16 Apr 2024
Q3 2022 -$3.31K -$5.44K +$15.4K +73.9% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$18.7K $1.08K +$53.8K 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$72.5K -$31.1K -$6.85K -28.2% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$65.7K $32.1K +$53.8K 01 Oct 2021 31 Dec 2021 10-K 18 Apr 2023
Q3 2021 -$119K -$20.8K +$4.8K +18.7% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$124K -$52.7K +$918 +1.71% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$125K -$24.2K +$5.89K +19.5% 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022
Q4 2020 -$131K -$21.7K +$20.9K +49.2% 01 Oct 2020 31 Dec 2020 10-K 15 Apr 2022
Q3 2020 -$152K -$25.6K +$6.26K +19.6% 01 Jul 2020 30 Sep 2020 10-Q 22 Nov 2021
Q2 2020 -$158K -$53.7K -$49K -1052% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 -$109K -$30.1K -$431 -1.45% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 -$109K -$42.6K -$21.7K -104% 01 Oct 2019 31 Dec 2019 10-K 15 Apr 2021
Q3 2019 -$87.1K -$31.9K 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 -$4.66K 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 -$29.7K 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 -$20.9K 20 Dec 2018 31 Dec 2018 10-K 30 Mar 2020

NP Life Sciences Health Industry Group Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$690 +$18.2K +96.3% 01 Jan 2023 31 Dec 2023 10-K 16 Apr 2024
2022 -$18.9K +$46.8K +71.3% 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024
2021 -$65.7K +$65.4K +49.9% 01 Jan 2021 31 Dec 2021 10-K 18 Apr 2023
2020 -$131K -$22.2K -20.4% 01 Jan 2020 31 Dec 2020 10-K 15 Apr 2022
2019 -$109K 01 Jan 2019 31 Dec 2019 10-K 15 Apr 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.